Resource Center

Free Case Review

Injured by a prescription drug or medical device? you may be entitled to compensation.

Lawsuit Filed Over Injuries from Recalled Stryker LFIT V40 Femoral Head

A Rhode Island resident recently filed a lawsuit against Stryker, alleging she suffered from side effects caused by a recalled LFIT V40 femoral head component.
The plaintiff in this newest Stryker lawsuit, Mary G., was implanted with an LFIT V40 femoral head in March 2010.
Because of these complications, Mary claims, she had the LFIT V40 femoral head explanted in January 2014.
This is just the latest in a number of lawsuits Stryker faces over its recalled LFIT V40 femoral head device, with plaintiffs claiming that they were not adequately warned about the risks.
If you or someone you love have suffered from side effects after implantation with the recalled LFIT V40 femoral head, and even had to have the device removed, you may be able to file a lawsuit against Stryker and receive compensation.
The Stryker recall came after reports of side effects were associated with Stryker’s V40 femoral head component, including metallosis.
Several other Stryker hip products that can be used with the V40 femoral head were affected by the Stryker V40 femoral head recall.
In many cases, serious side effects like device failure or metallosis can require revision surgery to fix, replacing the defective implant.
Filing a Lawsuit Over the Recalled LFIT V40 Femoral Head If you or someone you love was implanted with a metal hip implant containing the recalled LFIT V40 femoral head and have suffered from these or other side effects, you may be able to file a class action lawsuit.
The Recalled LFIT V40 Femoral Head Lawsuit is Case No.

DePuy ASR Hip Implant Lawsuit Alleges Revision Surgery Left Woman in Permanent Pain

Johnson & Johnson and subsidiary DePuy Orthopaedics are facing an ASR hip implant lawsuit.
Plaintiff Kimberly O. and her husband are named plaintiffs in the case filed as a short form complaint as part of a multidistrict litigation.
Kimberly says she underwent a DePuy ASR hip implant surgery on her left hip in May 2006.
As a result of her alleged complications, Kimberly said she underwent a revision surgery to have the ASR hip implant removed in May 2017.
Since the revision surgery, she alleges she has continued to suffer pain throughout the time she has been recuperating, rehabilitating and undergoing physical therapy.
Kimberly’s “ability to perform normal physical activities has been and will be consequently limited,” said the complaint.
DePuy ASR Hip Implant Sparks Lawsuits Johnson & Johnson has paid $4 billion to settle around 8,000 ASR hip implant lawsuits, most of which accused the metal-on-metal implant systems of causing metal poisoning, known as metallosis.
The DePuy ASR hip implant allegedly causes metal components to rub against one another.
The ASR Hip Implant Lawsuit is Case No.
1:18-dp-20025-JJH and is part of the DePuy ASR MDL, In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation, MDL No.

Misdiagnosed Cervical Cancer Could Result from Misread Pap Test

If you or a loved one has had misdiagnosed cervical cancer, their Pap smear might have been misread.
A misdiagnosed cervical cancer lawsuit investigation is seeking patients who were diagnosed with cervical cancer within the last five years after obtaining a negative (normal) Pap test result.
Misdiagnosed Cervical Cancer Resulted in Death Women who receive a negative (cancer-free) notice after their Pap test should rarely receive a cervical cancer diagnosis upon obtaining their next exam.
An abnormal Pap test result does not necessarily mean precancerous or cancerous cells are present, but it does mean more testing will be needed.
Pap Test Results Vary According to the Centers for Disease Control and Prevention, a Pap test result is designated normal, unclear, or abnormal.
Normal: A normal is a negative result, which means that the cervix showed no changes in cellular structure.
Medical labs test millions of slides of Pap smears annually.
It’s possible misdiagnosed cervical cancer occurs due to fatigue of the person examining the cells.
Still, medical labs are responsible for testing the samples they receive and accurately interpreting those results.
If you were diagnosed with cervical cancer within the last five years, or if your loved one died of cervical cancer, and a medical lab failed to identify the cancer on a Pap smear test, you may have a legal claim.

Zinbryta Encephalitis Reports Lead to Drug’s Voluntary Recall

Due to reports of Zinbryta encephalitis linked to a popular multiple sclerosis medication, Zinbryta was voluntarily recalled off the markets by the drug’s manufacturers Biogen and Abbvie.
Following reports of adverse side effects including Zinbryta encephalitis, the manufacturers announced on March 2, 2018 that they were voluntarily recalling Zinbryta from international markets.
Adverse side effects associated have included serious skin reactions, liver failure, and serious inflammatory brain disorders, which includes encephalitis and meningoencephalitis.
Worldwide, there have been at least 12 cases of Zinbryta encephalitis reported.
According to the manufacturers of the drug, Biogen and AbbVie, the voluntary recall for Zinbryta was the result of safety concerns associated with the medication.
Prior to the voluntary recall announcement made by the companies, the European Medicines Agency had just previously stated that following cases of inflammatory brain disorders in patients taking Zinbryta, that they were “urgently reviewing” the drug.
Additionally, there will need to be collaborative work between the two companies and healthcare providers and regulators.
A risk management program was also added in the U.S.
Zinbryta encephalitis is a very serious complication that may result from Zinbryta drug use.
Although some people may exhibit no symptoms, common signs may include: Fatigue Fever Muscle pain or weakness Coordination problems Nausea or vomiting Headache Stiff neck Irritability Disorientation or mental confusion Join a Free Zinbryta Class Action Lawsuit Investigation If you or a loved one were diagnosed with encephalitis, liver injury, Stevens Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), or another complication after taking Zinbryta, you may have a legal claim.

Pharmacy Owner Pleads Guilty to Medicare and Medicaid Fraud

A pharmacy owner pled guilty to Medicare and Medicaid fraud charges in federal court located in Manhattan.
According to a DOJ press release, Sajid J., the named defendant, admitted to submitting over $8.5 million in claims for prescription medication he never dispensed from any of his pharmacies.
Additionally, in the DOJ statement, Berman noted that this Medicare and Medicaid fraud—part of a larger sting on the part of the Federal Bureau of Investigation (FBI) and the Department of Health and Human Services Office of Inspector General (HHS OIG)—contributed to a multi-billion dollar theft of the federal government.
The fraudulent claims were allegedly submitted between the first month of 2013 and mid-summer 2015.
During this time window, Sajid was allegedly able to obtain several million dollars in claim payments from the Medicare and Medicaid programs.
Sajid is 47 years old and resides in Fresh Meadows, Queens.
He is expected to be sentenced on August 24, 2018 and will serve up to five years in prison.
U.S. Congress established a five year incarceration penalty is the maximum for the associated crimes, but within this parameter the presiding federal judge is allowed discretionary powers.
The False Claims Act If you suspect an employer of committing fraud against a public health program, you may be able to file a legal action on the part of the United States government.
Fill out the form on this page now for a free, immediate, and confidential case evaluation.

More Patients Report Problems with Side Effects of Tasigna

The side effects of Tasigna can be very difficult for someone to deal with after the fact.
Some patients who have been negatively affected report that the manufacturers did not do enough to warn consumers and the medical community about the risks associated with the drug.
If you have been affected by side effects of Tasigna that include cardiovascular or circulatory issues after taking the chemotherapy medication, you may be eligible to participate in a class action investigation.
The side effects of Tasigna have been documented in over a dozen studies around the world, linking the cancer medication commonly used to treat chronic myeloid leukemia to a dangerous risk of medical conditions such as atherosclerosis.
Although all medications carry a risk, when manufacturers conceal or fail to disclose a serious side effect, patients may ultimately file a lawsuit against the drug’s makers.
Atherosclerosis May Be Side Effect of Tasigna Use Atherosclerosis is the medical terminology for the narrowing, clogging or hardening of the arteries.
Some of the most common side effects of Tasigna reported by consumers who have chosen to take legal action include infection, artery disease, embolic occlusion, heart attack, amputation, stroke and circulatory issues associated with the brain, heart or limbs.
This can lead to the development of peripheral arterial disease and is a serious side effect.
Patients who developed atherosclerosis after taking Tasigna may benefit from participating in a class action investigation.
Learning more about the rights of patients may be a natural next step.

Bard Seeks New Trial After Plaintiff Wins IVC Filter Bellwether Trial

Following a $3.6 million verdict in an IVC filter bellwether trial, Bard has filed a motion for a new trial, arguing that the court’s decision was inconsistent.
Bard filed their motion for a new trial on April 23, arguing that plaintiff Sherri B.
The company claimed that the IVC filter bellwether trial was particularly important because “the jury’s inconsistent verdicts threaten to undermine this purpose.” A bellwether trial is the first one conducted in a consolidation of lawsuits that often occurs in a multidistrict litigation.
The judge previously decided that Sherri’s case was sufficient and it became the IVC filter bellwether trial.
However, the jury found the company liable for negligently failing to warn the doctor who implanted the G2 filter about the shattering risks.
The IVC filter bellwether trial granted a $3.6 million award based on the negligent failure to warn claim.
The judgment as a matter of law motion requests that U.S. District Judge David Campbell undo the jury’s previous decision in the IVC filter bellwether trial and enter judgment in Bard’s favor.
The IVC Filter Lawsuit is Case No.
2:16-cv-00474 and is part of the IVC Filter MDL, In re: Bard IVC Filters Products Liability Litigation, Case No.
If you were implanted with an IVC filter, you may be entitled to compensation–even if you did not suffer complications.

Xarelto Bleeding Lawsuit Starts Second Trial In Attempt For Plaintiff Verdict

After the original $28.5 million verdict was overturned last year in post-trial motions in their Xarelto bleeding lawsuit, a second trial has begun in the Philadelphia County Court of Common Pleas.
One week later he was admitted into the hospital with life threatening internal bleeding.
“Who paid the price for their decision to remain silent?
Dan did,” Daniel’s attorney said to the jury.
All they had to do was tell people what they knew.” Xarelto Risk with Other Drugs During the time that Daniel was undergoing treatment, Bayer and Janssen were allegedly putting together a clinical study aimed at understanding the risk of Xarelto for patients also undergoing treatment with antiplatelet medication.
However, Bayer and Janssen argue that Xarelto’s label clearly states that there is an increased risk of bleeding events when prescribed with antiplatelet drugs.
They also argue that the two doctors who prescribed Xarelto to Daniel testified that they knew about the risks about bleeding events but the risk was outweighed by the benefit of preventing a stroke.
The manufacturers claim that they did not include the dosage recommendation in the label because there was no good data at the time that the label was written.
Three federal cases in a multidistrict litigation program tried in Louisiana all recently ended in a defense verdict.
The Xarelto Bleeding Lawsuit is Case No.

Exactech Knee Implant Components Might Wear Out or Contain Recalled Parts

An independent observer followed up with patients between 12 and 42 months, with the mean follow-up time of 25 months.
In less than five years, 13 Exactech knee implants were revised due to tibial loosening, patellofemoral instability or patellofemoral pain.
Patients experiencing pain, mobility issues, swelling, fluid retention in the joint, instability, or a warm and inflamed joint might be in need of an Exactech knee implant revision surgery.
Exactech Knee Implant Recalls In the fall of 2017, the FDA announced a Class 2 device recall of the Optetrak Offset Tibial Tray and Screws.
Previously, in 2012, the Optetrak Logic Posterior Stabilized Tibial Insert, Size 6 was recalled due to a defective design.
The FDA’s Manufacturer and User Facility Device Experience (MAUDE) reports allege revision surgeries were needed due to “loose tibial component” and “pain, limited mobility, knee swelling and sensitivity.” Similar complaints reportedly were received in 2013.
Exactech Merges with TPG Capital Exactech merged with TPG Capital in February.
A patient who receives a knee revision surgery faces an increased risk of blood clots, bone loss and infection.
If you have undergone an Exactech knee implant surgery and suffered adverse side effects or needed revision surgery, you could qualify for compensation through legal representation.
Get a Free Knee Replacement Case Review If you or a loved one suffered from complications caused by an Attune knee implant, an Arthrex knee implant, or an Exactech knee implant, you may have a legal claim.

Antibiotic Levofloxacin Linked with Serious Complications

Those who take the antibiotic levofloxacin may be at risk of developing serious, and even life-threatening complications, including an aortic aneurysm or dissection.
The antibiotic levofloxacin is what is known as a fluoroquinolone drug.
According to the study, the use of the antibiotic levofloxacin and other fluoroquinolones was associated with a 66 percent increased rate of an aortic aneurysm or dissection.
An aortic tear is a potentially life-threatening problem that can lead to heart attack, stroke, and other serious complications, Unfortunately, patients may be unaware that the popular antibiotic Levaquin may be one of the aortic tear causes, placing them at serious risk.
If you or someone you love has suffered from aortic tearing or other side effects after using Levaquin, you may be able to file a lawsuit.
Side Effects of Fluoroquinolones Patients taking the antibiotic levofloxacin face an increased risk of an aortic aneurysm.
Patients also face an increased risk of aortic dissection.
When the aorta tears, blood can move into the aortic wall, weakening the wall’s layers as it pushes between them, which can cause dangerous or even fatal rupturing or leaking problems.
Antibiotic Levofloxacin Legal Claims Manufacturers of fluoroquinolone drugs like levofloxacin (Levaquin) have been hit with dozens of lawsuits so far.
These lawsuits claim that these drugs caused serious or debilitating injuries and that drug manufacturers failed to give adequate warning about these potentially serious antibiotic side effects to the public and to the medical community.